104 related articles for article (PubMed ID: 1034919)
1. Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems.
Randrup A; Mogilnicka E
Pol J Pharmacol Pharm; 1976; 28(6):551-6. PubMed ID: 1034919
[TBL] [Abstract][Full Text] [Related]
2. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
Costall B; Naylor RJ
Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
[TBL] [Abstract][Full Text] [Related]
3. The effect of alpha-adrenergic receptor stimulant drugs on amphetamine or apomorphine-induced stereotypy in rats.
Zebrowska-Lupina I; Kleinrok Z; Kozyrska C; Wielosz M
Pol J Pharmacol Pharm; 1978; 30(4):459-67. PubMed ID: 33370
[TBL] [Abstract][Full Text] [Related]
4. The effect of baclofen and aminooxyacetic acid on the action of drugs stimulating the dopaminergic system.
Sypniewska M
Pol J Pharmacol Pharm; 1978; 30(6):755-66. PubMed ID: 573471
[TBL] [Abstract][Full Text] [Related]
5. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
[TBL] [Abstract][Full Text] [Related]
6. The influence of antiserotonergic agents on the action of dopaminergic drugs.
Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
[TBL] [Abstract][Full Text] [Related]
7. Amantadine and apomorphine: interactions on striatal dopamine receptors.
Cox B
Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
[No Abstract] [Full Text] [Related]
8. Effect of angiotensin on the central action of dopamine.
Braszko J; Wiśniewski K
Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
[TBL] [Abstract][Full Text] [Related]
9. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
Kulkarni SK; Dandiya PC
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
[TBL] [Abstract][Full Text] [Related]
10. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
Jagiełło-Wójtowicz
Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
[TBL] [Abstract][Full Text] [Related]
11. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
Swiderska D; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
[TBL] [Abstract][Full Text] [Related]
12. Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats.
Grabowska M
Arch Immunol Ther Exp (Warsz); 1975; 23(6):753-61. PubMed ID: 1241267
[TBL] [Abstract][Full Text] [Related]
13. Participation of prostaglandins E2 and F2 alpha in the action of fibrinopeptides A and B on the central dopaminergic system.
Swiderska D; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1986; 38(1):29-39. PubMed ID: 3463941
[TBL] [Abstract][Full Text] [Related]
14. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
15. Supersensitivity following repeated administration of dopaminergic agonists.
Westermann KH
Acta Physiol Pharmacol Bulg; 1982; 8(1-2):58-63. PubMed ID: 6889805
[No Abstract] [Full Text] [Related]
16. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
Kozyrska C; Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
18. The role of some prostaglandins in the interaction of fibrinogen degradation products (FDP) with central dopamine receptors of rats.
Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1979; 31(5):473-80. PubMed ID: 575732
[TBL] [Abstract][Full Text] [Related]
19. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates.
Abrams DR; Bruno JP
Dev Psychobiol; 1992 Nov; 25(7):475-95. PubMed ID: 1459343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
